baber/WOPTO huggingface dataset:
Patent NZ-580905-A (NZ)
Title: Toner and toner waste integrated cartridge for electrographic printer
Inventor: INOMATA MITSUGU
IPC: G03G15/095
Filed: 2009-11-03
Abstract: A developer storing vessel 1 includes a supplied developer storing portion 41 and a recovered developer storing portion 42. The supplied developer storing portion includes: a first supply storing portion 4la in which a developer to be supplied to a developer unit Gy-Gk is stored; a second supply storing portion 4lb beneath the first supply storing portion 4la and formed with a horizontal width narrower than that of the first supply storing portion; and a supply outlet 41c out from which the developer stored in the second supply storing portion (41b) flows. The recovered developer storing portion 42 includes a recovery inlet 42c which is disposed above the supply outlet 41c in a direction of gravity, in a position displaced 10 there-from horizontally and within the horizontal width of the first supply storing portion 4la, and into which recovered developer flows, and a recovery storing portion 42a which is provided beneath the recovery inlet 42c and in which the developer flowing from the recovery inlet (42c) is stored.
Patent NZ-580963-A (NZ)
Title: Compositions and methods for prophylaxis and treatment of addictions
Inventor: CICCOCIOPPO ROBERTO
IPC: A61K31/70
Filed: 2008-04-11
Abstract: Disclosed are methods of treating or preventing addiction and relapse use of addictive agents, and treating or preventing addictive or compulsive behaviour and relapse practice of an addictive behaviour or compulsion, by administering a peroxisome proliferator-activated receptor gamma (PPAR) agonist, alone or in combination with another therapeutic agent, such as, for example, an opioid receptor antagonist or an antidepressant. The present invention also includes pharmaceutical compositions for treating or preventing addiction or relapse that include a PPAR agonist and one or more other therapeutic agents, as well as unit dosage forms of such pharmaceutical compositions, which contain a dosage effective in treating or preventing addiction or relapse. The methods and compositions of the invention are useful in the treatment or prevention of addiction to any agent, including alcohol, nicotine, marijuana, cocaine, and amphetamines, as well as compulsive and addictive behaviours, including pathological gambling and pathological overeating.
Patent NZ-588143-A (NZ)
Title: Oxazole, imizadole and pyrrole derivatives as NF-kappaB inhibitors (NF-kB)
Inventor: LEBAN JOHANN
IPC: A61K31/4535
Filed: 2005-07-29
Abstract: Disclosed are oxazole, imidazole, and pyrrole derivatives of the pictured formula, where R4 and R5 may join to form a ring, as may Z and R1 and wherein the substituents are otherwise defined in the specification. Also disclosed is the use of the compounds as NF-kappa B inhibitors, for treating diseases characterized by hyperproliferation of cells.
Patent NZ-588372-A (NZ)
Title: Diphenyl ether or thioether derivatives for treatment of autoimmune diseases
Inventor: ALBERT RAINER
IPC: A61K31/137
Filed: 2006-09-07
Abstract: The disclosure relates to amino alcohol derivatives of formula (Ia), pharmaceutically acceptable salt thereof and a phosphate derivate thereof, and more specifically to their use to treat particular autoimmune diseases, such as amyotrophic lateral sclerosis, Guillain-Barre syndrome and uveitis.
Patent NZ-590328-A (NZ)
Title: Sphingosine 1 phosphate receptor modulators and their use to treat polymyositis and dermatomyositis
Inventor: AHMED SYED SOHAIL
IPC: A61K31/397
Filed: 2009-07-22
Abstract: Disclosed is the use of an sphingoshine 1 phosphate (S1P) receptor modulator of formula Ia, or an N-oxide derivative or ester, amide, individual isomer and mixtures of isomers, or a pharmaceutically acceptable salt, solvate or hydrate thereof, wherein the substituents are as described within the specification, in the preparation of a medicament for preventing, inhibiting or treating an inflammatory condition selected from polymyositis or dermatomyositis.
Patent NZ-590403-A (NZ)
Title: Method and control system for controlling power conversion in a power converter
Inventor: FULCHER ROBERT VERNON
IPC: H02M7/5387
Filed: 2011-01-10
Abstract: A control system for controlling conversion of an input power into an output power in at least one converter module (27) is disclosed. The at least one converter module comprises at least one input power terminal, at least one output power terminal, and for each output power terminal at least one active switching device (35) connected between an input power terminal and the respective output power terminal, by controlling the timing of the switching of the at least one active switching device. The control system comprises a master controller (33) and for each converter module controlled by the master controller, a communication link (40) interconnecting the master controller and the respective converter module. A timing generator (45) generates a timing signal having a cycle time equal to or less than the shortest time constant of the converter modules and the immediate power circuit elements relating to the used respective converter module. The timing generator is integrated in or interconnected with the master controller. A signal generator (46) is integrated in or interconnected with the master controller and generates switching control signals. Each switching control signal contains a control message defining a switching state for the at least one active switching device (45) in a converter module interconnected with the master controller. The duration of each control message is equal to or less than the cycle time. The communication links are serial communication links.
Patent NZ-594901-A (NZ)
Title: Cooked chees with phospholipid supplement and withoug significant level of emulsifying salts
Inventor: ROESCH RODRIGO R
IPC: A23C19/00
Filed: 2011-08-30
Abstract: Provided is a cooked cheese product, comprising: at least one natural cheese in the range of 20 to 92 percent weight; a protein supplement in the range of 0.25 to 30 percent weight; and a phospholipid supplement in the range of about 0.1 to 1 percent weight; wherein the cooked cheese product is homogeneous and does not contain significant levels of emulsifying salts. The cheese has good organoleptic qualities and does not separate oil when heated.
Patent NZ-596963-A (NZ)
Title: Compositions for continuous administration of dopa decarboxylase inhibitors
Inventor: NEMAS MARA
IPC: A61P25/16
Filed: 2010-05-17
Abstract: 596963 Disclosed are arginine salts of carbidopa and compositions that include for example the arginine salt of carbidopa suitable for continuous administration for treating neurological or movement diseases or disorders such as restless leg syndrome, Parkinson’s disease, secondary parkinsonism, Huntington’s disease, Parkinson’s-like syndrome, PSP, MSA, ALS, Shy-Drager syndrome and conditions resulting from brain injury including carbon monoxide or manganese intoxication, together with administration of levodopa. The pharmaceutically acceptable liquid composition comprises arginine and carbidopa, wherein the composition comprises about 1 % or about 2% to about 6% by weight carbidopa; the liquid composition has a pH of about 6.5 to about 9.5 at 25°C; and the liquid composition is substantially stable at 25°C for 48 hours or more.
Patent NZ-620429-A (NZ)
Title: Method for producing fine particles of aripiprazole anhydride crystals b
Inventor: BANDO TAKUJI
IPC: C07D215/22
Filed: 2012-06-29
Abstract: Disclosed herein is a method for producing fine particles of aripiprazole anhydride crystals B less than 50 µm in size, comprising the steps of: (a) heating and dissolving crude aripiprazole in a lower alcohol selected from the group consisting of methanol and ethanol, and subsequently cooling the resulting mixture to precipitate crystals to obtain crystals of aripiprazole lower alcohol solvate; (b) subjecting the crystals of aripiprazole lower alcohol solvate to wet-milling in the form of a slurry containing the lower alcohol; and (c) subjecting the dispersion of the wet-milled crystals to solid-liquid separation to obtain the crystals, and heating the crystals to dry. In one embodiment the volume average particle size of the wet-milled crystals in step (b) is 15 to 20 µm. Aripiprazole is known as 7-{ 4-[4-(2,3-dichlorophenyl)-I-piperazinyl]butoxy} -3,4-dihydrocarbostyril or 7-{ 4-[4-(2,3-dichlorophenyl)-Ipiperazinyl]butoxy} -3,4-dihydro-2(IH)-quinolinone.
Patent NZ-623439-A (NZ)
Title: Prevention and treatment of ocular conditions
Inventor: KNAPPE THOMAS
IPC: A61P27/02
Filed: 2012-10-11
Abstract: Disclosed is a pharmaceutical composition comprising hydrogel-linked carriers bound to drug compounds to form a controlled release drug delivery system for use in the treatment, prevention and/or diagnosis a condition of the eye and ophthalmic devices comprising said pharmaceutical compositions.
Patent NZ-630990-A (NZ)
Title: Aminoacid lipids
Inventor: PLATSCHER MICHAEL WILHELM
IPC: C07C271/22
Filed: 2013-03-11
Abstract: The present disclosure is directed to a new class of lipids, more specifically ether-lipids having a polar headgroup, as well as vesicles comprising these lipids, methods of their preparation as well as their uses in medical applications, wherein the ether-lipids are represented by general formula (I) wherein Y represents O, N, S or a covalent bond; P1 represents H, an Y- protecting group or an Y-activating group or a spacer group; P2, P3 represent independently of each other H, an amino-protecting group or a spacer group, or P2 and P3 form together with the N to which they are bound a ring structure; L is a group of formula (a) wherein the dashed line represents the linkage to N; R1 represents H or a group of formula -(CH2)2-ORb1; R1 represents H or a group of formula - (CH2)2-ORb2, R2 represents H or a group of formula -CH2-ORc; R2 Represents H or a group of formula -ORd or -CH2-ORc,’ R2 represents H or a group of formula -(CH2)2-ORe or -(CH2)3-ORe; Ra, Rb1, Rb2, Rc, Rd,Re represent independently of each other a saturated or unsaturated, straight or branched hydrocarbon chain, and m is 1, 2 or 3; with the proviso that at least one of R1, R1’, R2, R2’, R3 is not H.
Patent NZ-631289-A (NZ)
Title: Improved compositions for treating muscular dystrophy
Inventor: EDWARD M KAYE
IPC: C12N15/113
Filed: 2014-03-14
Abstract: Provided is the use of eteplirsen for the manufacture of a medicament for the treatment of Duchenne muscular dystrophy (DMD) in a patient who has a mutation of the DMD gene that is amenable to exon 51 skipping, wherein the medicament is adapted to be administrable intravenously to the patient at a dose of about 30 mg/kg weekly for more than 120 weeks.
Patent NZ-700296-A (NZ)
Title: Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites
Inventor: MACKEL MICHAEL JOHN
IPC: A61P35/00
Filed: 2010-11-10
Abstract: Discloses use of an effective amount of an R-G-Cysteic Acid Peptide, or a functional derivative thereof selected from the group consisting of a pharmaceutically acceptable salt, hydrate, stereoisomer, multimer, cyclic form, linear form and drug-conjugate, in the manufacture of a medicament for inhibiting adhesion to RGD binding sites in a human or animal subject, provided that the R-G-Cysteic Acid Peptide is not Glycine- Arginine-Glycine-Cysteic(Acid)-Threonine-Proline.
Patent NZ-710020-A (NZ)
Title: Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
Inventor: HONDMANN DIRK
IPC: A61K38/07
Filed: 2014-03-11
Abstract: The present disclosure relates to nutritional compositions comprising a protein equivalent source, wherein 20% to 80% of the protein equivalent source includes a peptide component comprising SEQ ID NO 4, SEQ ID NO 13, SEQ ID NO 17, SEQ ID NO 21, SEQ ID NO 24, SEQ ID NO 30, SEQ ID NO 31, SEQ ID NO 32, SEQ ID NO 51, SEQ ID NO 57, SEQ ID NO 60, and SEQ ID NO 63, and 20% to 80% of the rotein equivalent source comprises an intact protein, a partially hydrolyzed protein, or combinations thereof. The disclosure further relates to methods of reducing the inflammatory response and/or production of proinflammatory cytokines, i.e. Interleukin-17, by providing said nutritional compositions to a target subject.
Patent NZ-723209-A (NZ)
Title: Extracellular polysaccharide with immunomodulatory effect and preparation method and use thereof
Inventor: GUO BENHENG
IPC: C12R1/225
Filed: 2014-09-05
Abstract: Disclosed are an extracellular polysaccharide with an immunomodulatory effect and a preparation method and use thereof. The extracellular polysaccharide consists of the following raw materials by mass fraction: 20.70-22.74% of glucosamine, 33.87-35.21% of glucose, 20.57-22.38% of arabinose, 11.85-12.74% of galactosamine and 8.74-11.20% of galactose, wherein the weight-average molecular weight is 11,864-15,473 daltons.
Patent NZ-726179-A (NZ)
Title: Head massager and helmet size adjustment structure therefor
Inventor: MA XUEJUN
IPC: A61H37/00
Filed: 2015-01-20
Abstract: The present invention relates to a head massager and a helmet size adjustment structure therefor. In prior art designs, to adjust a helmet for an existing head massager in terms of size it is generally required that a first housing and a second housing is moved using a pulling action by hand. This kind of structure, which requires manual spacing adjustment, is not easy to operate and has relatively poor reliability. To address these problems, the present invention provides an adjusting apparatus that allows the helmet size to be adjusted through rotating and pressing actions. The helmet size adjustment structure comprises two racks (300) and an adjusting apparatus (400), the adjusting apparatus (400) comprising a rotary shaft (410) and a gear wheel (420), an upper part and a lower part of the gear wheel (420) respectively meshing with the racks (300), and a knob assembly (500) and a locking assembly (600) being provided on the rotary shaft (410), and further comprising two draw springs (700), the front end of each draw spring (700) being fixed onto a rear housing (200), the rear end of each draw spring (700) being respectively fixed onto the two racks (300). The knob assembly (500) comprises a knob outer ring (510), a knob outer shell (520), and a gear wheel seat (530). The locking assembly (600) comprises a knob fastener (610), a knob fastener upper cover (620) and an elastic member (630). The gear wheel seat (530) is located in the knob fastener (610), a one-way toothed ring (531) is provided on the gear wheel seat (530), a fastener (611) capable of clamping on the one-way toothed ring (531) is provided on the knob fastener (610), the elastic member (630) is arranged on the knob fastener upper cover (620), teeth (532) are also provided on the gear wheel seat (530), and the teeth (532) mesh with the gear wheel (420), wherein the knob is designed as one piece with a push-button. The helmet is adjusted by two methods, the operating structure is more convenient and the internal structure is more reliable.
Patent NZ-738096-A (NZ)
Title: Compact spraying module, system for spraying and controlling a plurality of such modules, and method for controlling modules of such a system
Inventor: PELLENC ROGER
IPC: B05B3/10
Filed: 2016-06-23
Abstract: The present invention relates to a compact spraying module for spraying a liquid in the form of droplets (18) for treating a target. Said module includes a spraying unit (3) including a nozzle containing at least one spraying member and a fan that is capable of generating a carrying air flow in the nozzle and of carrying the droplets originating from said member to the target. Said module includes its own liquid supply system (7, 11) that and includes an electric pump (11), an electronic control and monitoring unit, a holder that keeps said pump near the spraying unit, an individual communication interface (20), and a power supply interface (20’). The invention also relates to a system for spraying and controlling a plurality of such modules and to a method for controlling modules of such a system.
Patent NZ-739402-A (NZ)
Title: System and method for dynamically scheduling wireless transmissions without collision
Inventor: BENNETT JUSTIN
IPC: H04W40/24
Filed: 2016-07-13
Abstract: A system and method dynamically schedule wireless transmissions without collision. A master transmitter periodically transmits a time mark during a first predefined time slot of a plurality of consecutive time slots that form a transmission block. Multiple consecutive transmission blocks form a frame. An announcement transmission from a wireless transmitting device is received via at least one receiver during a second predefined time slot of the plurality of time slots. An allocator allocates, at least partly based upon the received announcement transmission, a third time slot of the plurality of time slots to the wireless transmitting device. A time slot reservation area of at least one subsequently transmitted time mark includes indication of the allocation of the third time slot to the wireless transmitting device. The wireless transmitting device receives the subsequently transmitted time mark and transmits only during the third time slot of subsequent frames.
Patent NZ-743446-A (NZ)
Title: Water diverter
Inventor: ROBERT WILLIAM STRETTON
IPC: E04D13/08
Filed: 2016-12-22
Abstract: A water diverter comprising: an upstream body configured to connect to an upstream section of a downpipe in use, including: a filter; and a cavity between the filter and an exterior of the upstream body; and a downstream body, configured to connect to a downstream section of a downpipe and to the upstream body in use; and at least one outlet for diverted water, wherein the cavity is configured so that the upstream section of downpipe can be inserted into the cavity; and wherein the upstream body is slidable relative to the upstream section of downpipe within a suitable range to facilitate installation of the water diverter to a downpipe. This addresses problems with installation and retrofitting to existing downpipes.
Patent NZ-746054-A (NZ)
Title: Methods of treating cancer
Inventor: KEILHACK HEIKE
IPC: C12Q1/68
Filed: 2013-10-15
Abstract: The present invention discloses use of a therapeutically effective amount of an EZH2 inhibitor in the manufacture of a medicament for treating or alleviating a symptom of a cancer in a subject, wherein the cancer is not malignant rhabdoid tumor and epithelioid sarcoma, and wherein the EZH2 inhibitor is selected from the group consisting of Compound A, Compound B, Compound and Compound D, or a pharmaceutically acceptable salt thereof, wherein the cancer is a SWI-SNF-associated cancer.
Patent NZ-751182-A (NZ)
Title: Connection of structural components in a building structure
Inventor: KENNELLY BERNARD JOSEPH
IPC: E04B7/04
Filed: 2017-09-06
Abstract: In conventional assembly methods, heavy reliance must be placed on installer skill and diligence for the purposes of ensuring reliable interconnection of the components in the framework. This problem is addressed by providing a fastener pre-applied to a component to be fastened (typically being a pre-assembled roof truss) so that typically when the truss and a top plate of a wall are in abutment sliding is allowed (not precluded) before fixing the truss to the top plate.
Patent NZ-758906-A (NZ)
Title: System and methods for 3d model evaluation
Inventor: WARNER GLENN
IPC: G06T19/00
Filed: 2018-05-08
Abstract: A method, in each of three orthogonal orientations, obtains dimensional layers of triangular mesh data of the 3D object from a slicer program. Perimeter length values for each layer of each of the three orthogonal orientations are obtained and compared to stored perimeter length value for a reference object to determine a degree of matching. Measurement data is facilitated by processing by CNC/3D print software. Smaller objects within the 3D object are also analyzed. For a more robust approach, each triangle in the triangular mesh data is analyzed by totaling the perimeter of surrounding triangles to assign a value. Matching with the reference object is made based on the assigned total perimeter values. The 3D object can be scaled in one, two or three orthogonal dimensions to match the reference object.
Patent NZ-773712-A (NZ)
Title: Syringe devices
Inventor: ROLFS BRYAN
IPC: A61M5/31
Filed: 2016-03-17
Abstract: Described herein are syringe devices 100 comprising a syringe including a therapeutic dose of at least one drug, a needle and a stopper. The syringe is housed and/or placed in an encasement 106. The encasement 106 includes a window 134 which allows visual inspection of the drug, and a needle guard 104 that includes a window that aligns with the encasement window 134 when the needle guard 104 is not deployed. The needle guard 104 is manually deployed by moving the needle guard 104 away from the proximal end of the encasement 106 to cover the needle. The guard is permanently locked in position after deployment. The guard protects from accidental needle sticks after use.
Patent PT-101631-A (PT)
Title: Crankshaft-type distribution shaft for combustion engines
IPC: F01L1/00
Filed: 1995-01-09
Abstract: This distribution system is characterized in that the valve is controlled directly by the crankshaft by means of a small connecting rod articulated to the base of the valve, by an elastic element (made from metal or another material). The crankshaft is actuated by the drive shaft, opening the valve for the time required owing to the angle which the crank forms with the respective valve. Simplicity, economy and efficiency are the principal advantages of this system over conventional devices. <IMAGE>
Patent PT-103824-A (PT)
Title: Materiais compósitos de gesso
Inventor: EIRES RUTE
IPC: E04B1/62
Filed: 2007-09-13
Abstract: A PRESENTE INVENÇÃO REFERE-SE A MATERIAIS COMPÓSITOS DE GESSO, COMO BLOCOS E PLACAS, COM INCORPORAÇÃO DE MATERIAIS PASSÍVEIS DE RESULTAREM COMO SUBPRODUTOS DE PROCESSOS INDUSTRIAIS. O GESSO UTILIZADO PODE SER COMERCIAL OU OBTIDO COMO SUBPRODUTO INDUSTRIAL. OS MATERIAIS INCORPORADOS NO GESSO SÃO GRANULADO DE CORTIÇA, FIBRAS TÊXTEIS (OBTIDAS DE RESÍDUOS INDUSTRIAIS COMO POR EXEMPLO FIBRAS TÊXTEIS DE PNEUS, TECIDOS OU DESPERDÍCIOS DO FABRICO DE SAPATOS) E PASTA DE PAPEL RECICLADO, QUE COMBINADOS EM PERCENTAGENS ATÉ 50%, 30% E 20% DO VOLUME DE GESSO RESPECTIVAMENTE PARA CADA MATERIAL, RESULTAM NUM PRODUTO APLICÁVEL À CONSTRUÇÃO, PARTICULARMENTE EM PAREDES DIVISÓRIAS E REVESTIMENTOS INTERIORES DE EDIFÍCIOS. ESTE PRODUTO MANTÉM UM DESEMPENHO MECÂNICO COMPATÍVEL COM AS APLICAÇÕES PRETENDIDAS, COM A VANTAGEM DE APRESENTAR MELHORES PROPRIEDADES TÉRMICAS E ACÚSTICAS. ADICIONALMENTE, A RESISTÊNCIA A ÁGUA E A FUNGOS OU BACTÉRIAS É MINIMIZADA COM A INCORPORAÇÃO DE UMA PERCENTAGEM MÍNIMA DE ADITIVOS (ÓLEOS NATURAIS OU SÍNTÉTICOS E SAIS MINERAIS).
Patent RO-94168-A (RO)
Inventor: WEBB JOHN THOMAS HIRD
IPC: B66D3/06
Filed: 1984-12-25
Abstract: A winch comprises a capstan (2) provided with a plurality of circumferential grooves (11). The grooves (11) comprise a high friction material and the density of the material of each groove (11) is different, so that the coefficient of friction of the cable bearing surface increases from the load end to the tail end of the capstan (2).
Patent RU-94021128-A (RU)
Inventor: SEMENOV G A
IPC: B63H1/36
Filed: 1994-06-02
Abstract: FIELD: shipbuilding. SUBSTANCE: propeller is made in form of streamlined wedge-shaped taper body whose pointed end carries flexible reinforced plate similar to tuna fin and blunt end is connected with ship's hull forming single streamlined system together with it. Back action of wedge is used for creation of thrust. Ship has two hulls, thus increasing ship's running speed and enhancing her stability and stabilization of course. Fins may be used as rudder and braking device. To use fins as rudders they are deflected to the same side through distance exceeding maximum width of propeller and to use them as braking device, they are deflected to different sides. EFFECT: minimum of drag and considerable reduction of fuel consumption. 3 cl, 2 dwg